Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1993 1
1994 5
1995 3
1996 5
1997 4
1998 6
1999 3
2000 6
2001 8
2002 10
2003 11
2004 8
2005 1
2006 8
2007 6
2008 7
2009 9
2010 9
2011 8
2012 8
2013 11
2014 14
2015 18
2016 12
2017 15
2018 18
2019 13
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

208 results
Results by year
Filters applied: . Clear all
Page 1
Integrated genomic analyses of ovarian carcinoma.
Cancer Genome Atlas Research Network. Cancer Genome Atlas Research Network. Nature. 2011 Jun 29;474(7353):609-15. doi: 10.1038/nature10166. Nature. 2011. PMID: 21720365 Free PMC article.
Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors.
Chung JH, Dewal N, Sokol E, Mathew P, Whitehead R, Millis SZ, Frampton GM, Bratslavsky G, Pal SK, Lee RJ, Necchi A, Gregg JP, Lara P Jr, Antonarakis ES, Miller VA, Ross JS, Ali SM, Agarwal N. Chung JH, et al. Among authors: Millis SZ. JCO Precis Oncol. 2019;3:10.1200/PO.18.00283. doi: 10.1200/PO.18.00283. Epub 2019 May 10. JCO Precis Oncol. 2019. PMID: 31218271 Free PMC article.
Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.
Bill KLJ, Seligson ND, Hays JL, Awasthi A, Demoret B, Stets CW, Duggan MC, Bupathi M, Brock GN, Millis SZ, Shakya R, Timmers CD, Wakely PE Jr, Pollock RE, Chen JL. Bill KLJ, et al. Among authors: Millis SZ. Oncologist. 2019 Jul;24(7):989-996. doi: 10.1634/theoncologist.2019-0047. Epub 2019 Apr 24. Oncologist. 2019. PMID: 31019022 Free PMC article.
BRCA1/2 Functional Loss Defines a Targetable Subset in Leiomyosarcoma.
Seligson ND, Kautto EA, Passen EN, Stets C, Toland AE, Millis SZ, Meyer CF, Hays JL, Chen JL. Seligson ND, et al. Among authors: Millis SZ. Oncologist. 2019 Jul;24(7):973-979. doi: 10.1634/theoncologist.2018-0448. Epub 2018 Dec 12. Oncologist. 2019. PMID: 30541756 Free PMC article.
Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma.
Ang C, Klempner SJ, Ali SM, Madison R, Ross JS, Severson EA, Fabrizio D, Goodman A, Kurzrock R, Suh J, Millis SZ. Ang C, et al. Among authors: Millis SZ. Oncotarget. 2019 Jun 18;10(40):4018-4025. doi: 10.18632/oncotarget.26998. eCollection 2019 Jun 18. Oncotarget. 2019. PMID: 31258846 Free PMC article.
Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma.
Bridge JA, Sumegi J, Druta M, Bui MM, Henderson-Jackson E, Linos K, Baker M, Walko CM, Millis S, Brohl AS. Bridge JA, et al. Among authors: Millis S. Mod Pathol. 2019 Nov;32(11):1593-1604. doi: 10.1038/s41379-019-0301-1. Epub 2019 Jun 12. Mod Pathol. 2019. PMID: 31189996
Common Secondary Genomic Variants Associated With Advanced Epithelioid Hemangioendothelioma.
Seligson ND, Awasthi A, Millis SZ, Turpin BK, Meyer CF, Grand'Maison A, Liebner DA, Hays JL, Chen JL. Seligson ND, et al. Among authors: Millis SZ. JAMA Netw Open. 2019 Oct 2;2(10):e1912416. doi: 10.1001/jamanetworkopen.2019.12416. JAMA Netw Open. 2019. PMID: 31577358 Free PMC article.
208 results
Jump to page
Feedback